UK
anti-doping chief admits 'grave mistakes' after critical report
Send a link to a friend
[July 12, 2016]
(Reuters) - Britain's
anti-doping agency made a "ghastly mistake" in its handling of a
probe into the role of a doctor accused of supplying banned drugs to
athletes, the chairman of UK Anti-Doping (UKAD) David Kenworthy has
admitted.
The Sunday Times reported in April that Dr Mark Bonar prescribed
banned drugs to 150 sports figures including several Premier League
footballers.
Kenworthy's admission follows the publication of an independent
report commissioned by the government following the allegations.
The report was critical of UKAD, saying it was "difficult to
understand" why the anti-doping body did not pass on information
given by amateur cyclist Dan Stevens to the General Medical Council
(GMC), the regulatory body responsible for Dr Bonar.
"Frankly, I still do not know why we didn't -- we certainly talked
about it," Kenworthy was quoted as saying by the Guardian.
"It was a ghastly mistake and it should never have happened. Nobody
is disputing that."
The report revealed that the agency had been advised seven times by
Stevens and its own staff to notify the GMC, yet it failed to do so.
Dr Bonar claimed his "clients" included an England cricketer,
British Tour de France cyclists, a British boxing champion, tennis
players, martial arts competitors, and footballers.
[to top of second column] |
Despite the damaging nature of the report, Kenworthy, a former chief
constable of North Yorkshire, said UKAD was keen to learn from the
episode.
"I have worked for four police forces and chaired two national
charities, so I know everybody makes mistakes but that is how you
learn. I also know UKAD is still the best anti-doping organisation
in the world," he said.
"It's why the World Anti-Doping Agency asked us to pick up the
pieces in Russia, why we're providing know-how on intelligence-led
testing at the Rio Olympics."
(Reporting by Shravanth Vijayakumar in Bengaluru; Editing by Amlan
Chakraborty)
[© 2016 Thomson Reuters. All rights
reserved.]
Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |